Nicotrol and Nicoderm nicotine patches recommended for OTC approval.
This article was originally published in The Tan Sheet
Executive Summary
NICOTROL AND NICODERM UNANIMOUSLY RECOMMENDED FOR OTC USE on April 19 by FDA's Nonprescription Drugs Advisory Committee, which was joined by members of the agency's Drug Abuse Advisory Committee. In separate votes on the two products, the committee voted 9-0 that McNeil Consumer Products' Nicotrol and SmithKline Beecham's Nicoderm nicotine transdermal patches are safe and effective for over-the-counter use as smoking cessation aids.